Headlands Research Acquires AMCR Institute
Headlands Research has announced the acquisition of AMCR Institute, which has been in operation for more than 20 years. The site’s team brings experience in metabolic, endocrine, and medical device research to the growing clinical research site network.
Led by principal investigator (PI) Timothy S. Bailey, MD, FACE, FACP, CPR, the San Diego–based clinical research site specializes in metabolic, endocrine, and other chronic conditions such as type 1 and type 2 diabetes and obesity. Bailey is a board-certified endocrinologist and is certified by the Association of Clinical Research Professionals (ACRP). He and his staff have worked with thousands of volunteers in Phase I-IV trials and have extensive experience with the evaluation of medical devices such as continuous glucose monitors (CGMs).
The acquisition of AMCR Institute, now known as Headlands Research AMCR Institute, is the most recent as the company expands its clinical research site network to support more clinical trials and provide access to investigational therapies to a diverse, representative population. Headlands Research recently launched one new clinical research site and acquired two additional established sites: Headlands Research Detroit serves multiple therapeutic areas, including Alzheimer’s disease and vaccines; Headlands Research Eastern Massachusetts specializes in neurodegenerative diseases such as Alzheimer’s disease, and Clinvest Research specializes in chronic diseases including migraine and arthritis.
Reference
Headlands Research Acquires AMCR Institute, Adding Medical Device Expertise to the Clinical Research Site Network. (2023, July 27). Business Wire.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Integrated Multi-Omic Data: Powering Precision Medicine
March 10th 2025Genomics has long been a primary focus in precision medicine, but other areas of research are increasingly being used to help attain a more complete picture of how an individual’s complex biology impacts their health profile.
